CD19 CAR-macrophage suppressed the progression of DLBCL via modulating SYK/SHP2/TBK1/TFEB signaling
{{output}}
Objective: To explore the specific molecular mechanisms of CD19 CAR-Macrophage (CD19 CAR-M) in treating Diffuse Large B-cell Lymphoma (DLBCL). Methods: ... ...
